About: acn

KEY HIGHLIGHTS-  Revenue increased 7.7% year-on-year to HK$429.6 million-  Gross profit rose 23.2% to HK$253.6 million-  Profit attributable to equity shareholders increased 20.0% to HK$115.0 million-  Declared an interim dividend of HK9.75 cents per share-  Ho Chai Kung and Po Chai Pills achieved steady growth supported by strong marketing and brand execution- Cross-border e-commerce and concentrated Chinese medicine granules (CCMG) businesses remained resilient and contributed to stable performanceHONG KONG, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) – JBM (Healthcare) Limited (“JBM Healthcare” or the “Company”, Stock Code: 2161, together with its subsidiaries, the “Group”), a leading branded healthcare products marketer and distributor in Hong Kong, today announced its interim results for the six months ended 30 September 2025 (“FY2026 Interim” or the “Reporting Period”).Despite a challenging retail environment, JBM Healthcare delivered moderate growth, with revenue increasing by 7.7% to HK$429.6 million and profit attributable to equity shareholders rising by 20.0% to HK$115.0 million during the Reporting Period. The solid performance was underpinned by the strength of its flagship proprietary brands, diversified product portfolio, and disciplined execution. The Group continued to enhance brand equity and expand market reach through integrated marketing, e-commerce expansion, and strategic engagement initiatives across Hong Kong and the Greater Bay Area.Resilient Performance across Core SegmentsDuring the Reporting Period, the Branded Medicines segment achieved solid growth, led by the sustained momentum of Ho Chai Kung. Building on its reputation as a trusted over-the-counter remedy for pain and fever, the brand further strengthened its market presence through a series of high-impact marketing initiatives.Television advertising featuring brand ambassador Hins Cheung enhanced brand awareness and consumer engagement, while strategic sponsorships and event partnerships broadened audience reach. The brand also gained strong visibility through its participation in large-scale televised events, effectively connecting with both middle-aged and younger consumers.The Proprietary Chinese Medicines segment recorded notable growth, led by Po Chai Pills and supported by the CCMG business.During the period, Po Chai Pills launched its innovative “tear-and-take” sachet pack designed for convenient, on-the-go use. A lively TV commercial featuring Louis Koo, Tony Wu , and Bonnie Wong captured strong public attention, blending nostalgic charm with modern visuals and achieving millions of online views within weeks of launch, adding momentum for the brand. Complemented by community campaigns, youth outreach, and large-scale outdoor visibility, these initiatives further strengthened Po Chai Pills’ relevance across generations.The Health and Wellness Products segment recorded a moderate decline due to the rationalisation of certain products, partially offset by the solid and steady growth of the Oncotype DX Breast Cancer Recurrence Score Test. The test’s adoption continued to expand in both Hong Kong and Macau. Supported by ongoing collaboration with the Hong Kong Breast Cancer Foundation, the Group further advanced public education on genomic testing and precision medicine, reinforcing Oncotype DX’s position as a trusted diagnostic assay test that provides individualised data on tumor biology , helping doctors tailor a treatment plan specifically to the individual, ensuring appropriate therapy and increasing confidence in treatment decisions.  Expanding E-Commerce and TCM Market OpportunitiesDuring the Reporting Period, the Group further expanded its presence across leading cross-border e-commerce platforms such as Tmall Global, JD.com, and Alibaba Health. Ho Chai Kung and Po Chai Pills continued to perform strongly online. These efforts enhanced brand awareness, customer perceptions and product acceptance amongst the target prospects in Chinese MainlandIn the traditional Chinese medicine (TCM) market, the Group maintained stable performance in its CCMG business, supplying over 700 single- and combo-formula granules to a wide network of registered practitioners. To capture new market opportunities, JBM Healthcare is expanding its TCM portfolio with new products and an upgraded e-business platform designed to streamline ordering processes, enhance practitioner engagement, and integrate online and offline service experiences.Mr. Derek Sum, Executive Director of JBM Healthcare, commented, “Amid a challenging market, we sustained growth through disciplined execution and the continued strength of our flagship brands. Our diversified portfolio and expanding e-commerce footprint have reinforced JBM Healthcare’s resilience and competitiveness. Looking ahead, we will continue to enrich our product mix, deepen customer engagement, and capture opportunities across Hong Kong, the Greater Bay Area, and other key markets to deliver sustainable long-term value.”About JBM (Healthcare) Limited (Stock Code: 2161)JBM Healthcare is a Hong Kong-based company that markets and distributes branded healthcare products across Greater China, Southeast Asia, and other select countries. The Group is a distinctive player in the sector with marketing expertise and heritage in pharmaceuticals that prioritises product efficacy and quality to meet consumers' healthcare needs. As a renowned healthcare brand operator in Hong Kong, the Group carries a wide-ranging portfolio of branded healthcare products comprising branded medicines, proprietary Chinese medicines, and health and wellness products, which include well-recognised household brands such as Po Chai Pills, Ho Chai Kung Tji Thung San, Tin Hee Tong Tin Hee Pills, Contractubex, Tong Tai Chung Woodlok Oil , Flying Eagle Woodlok Oil , Saplingtan , Shiling Oil and Konsodona Medicated Oil . JBM Healthcare has been a constituent stock of the MSCI Hong Kong Micro Cap Index since 27 May 2021. For more details about JBM Healthcare, please visit: www.jbmhealthcare.com.hkFor media inquiries, please contact:Strategic Financial Relations LimitedVicky LeeTel: (852) 2864 4834Email: vicky.lee@sprg.com.hkRachel KoTel: (852) 2114 2370Email: rachel.ko@sprg.com.hkCoco YuTel: (852) 2864 4876Email: coco.yu@sprg.com.hk Fax: (852) 2527 1196 Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

TAIPEI, TAIWAN, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) - OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology.Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization[1]. At present, there are no FDA approved ADC therapies for cholangiocarcinoma.To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to experimental therapies that have the potential to treat these diseases. In the United States, a rare disease is defined as any condition that affects fewer than 200,000 patients. After granting Orphan Drug Designation, the US FDA qualifies companies or drug developers incentives such as tax credits for clinical trials, exemption from user fees, and marketing exclusivity[2].In August 2025, OBI launched a phase I/II clinical trial in the United States and Taiwan, recruiting patients with advanced solid tumors. The objectives of the trial are to study the safety, pharmacokinetics, and preliminary efficacy profile of OBI-902 in these patient populations.Heidi Wang, Ph.D, OBI Pharma's Chief Executive Officer noted, "Based on our preclinical data, OBI-902 has several important advantages over other TROP2 ADCs either approved or in development; including high stability in blood circulation, excellent bystander effect that extends the killing to neighboring cancer cells lacking TROP2 expression, potential ability to overcome drug resistance, and outstanding activity in animal and organoid models of cancer. Importantly, this marks the first time an ADC that incorporates OBI's proprietary GlycOBI® ADC technology is being evaluated in patients, including those diagnosed with cholangiocarcinoma. We look forward to investigating this potential best-in-class TROP2 ADC in the clinic."About OBI-902OBI-902 is a TROP2-targeted antibody-drug conjugate (ADC) that carries a potent topoisomerase I inhibitor payload to kill tumor cells and with a drug-antibody ratio (DAR) of 4. TROP2 is highly expressed in a variety of solid tumors such as breast, lung, biliary, bile duct (cholangiocarcinoma), ovarian, gastric, and many other cancer types, rendering it an ideal target for cancer therapy.OBI-902 is a novel site-specific glycan-conjugated ADC using OBI's proprietary GlycOBI platform, which provides improved stability and enhanced hydrophilicity. OBI-902 demonstrated remarkable antitumor efficacy, improved pharmacokinetic characteristics, and a favorable safety profile in various animal models. The IND of OBI-902 was cleared by the US FDA on April 30, 2025.Since December 2021, OBI has been granted by Biosion, Inc. (www.biosion.com) an exclusive, worldwide (except in China) license to a TROP2 targeting antibody amino acid sequence. Biosion holds exclusive rights to that antibody sequence in China. OBI holds worldwide commercial rights to OBI-902, except for the rights pertaining to the antibody in China.About GlycOBI®OBI has developed a unique clinical stage, glycan-based site-specific ADC technology (GlycOBI®), which is in a ‘Plug and Play' format and compatible with any antibodies, linkers, and payloads in drug-antibody ratio (DAR) up to 16. Utilizing OBI's proprietary dual-function enzyme (EndoSymeOBI®) and linker technology (HYPrOBI®), homogenous ADCs are manufactured with an efficient and scalable process under GMP conditions. The conjugation process of GlycOBI® avoids disrupting the antibody structure and ensures the ADC has similar biophysical characteristics to the native antibody. Furthermore, OBI's linker technology has improved conjugation efficiency of the payload, reduced aggregation propensity, which provides advantages on manufacturing ADC products. GlycOBI® conjugated ADCs have overcome the limitations of traditional ADCs and achieved better antitumor activity and stability in various in vivo animal studies. GlycOBI®, EndoSymeOBI®, and HYPrOBI® are part of the armamentarium of OBI's Obrion™ ADC Enabling Technologies that also include ThiOBI® and GlycOBI DUO™. OBI-902 is the first ADC utilizing OBI's Obrion™ ADC enabling technology for evaluation of safety and efficacy in Cancer, currently under Phase I/II clinical trial in the US and Taiwan.About OBI PharmaOBI is a clinical stage global oncology company that is headquartered in Taiwan and established in 2002. Its mission, together with its wholly owned subsidiary OBI Pharma USA, Inc., is to develop novel therapeutic agents for patients with high unmet medical needs.OBI's primary focus is the development of novel ADCs, including the first-generation cysteine-based TROP2 ADC, OBI-992. Using the company's proprietary ADC enabling technology, GlycOBI®, powered by EndoSymeOBI® and HYPrOBI®; OBI has created its next-generation novel ADC pipeline, including monospecific: OBI-902 (TROP2), OBI-904 (Nectin-4), bispecific single payload (HER2 x TROP2), and bispecific, dual payload (cMET x HER3) ADCs. To broaden the applicability of linker technology, HYPrOBI®, OBI further developed a novel ThiOBI® platform to enable irreversible cysteine-based conjugation. Additionally, OBI's pipeline includes the first-in-class AKR1C3-targeted small-molecule prodrug OBI-3424, which selectively releases a potent DNA-alkylating antitumor agent in the presence of the aldo-keto reductase 1C3 (AKR1C3) enzyme that is highly expressed in tumors. Additional information can be found at www.obipharma.com.GlycOBI®, EndoSymeOBI®, ThiOBI® and HYPrOBI®are registered trademarks of OBI Pharma. Obrion™ and GlycOBI DUO™ are trademarks under registration.1 National Institute of Health for Rare Diseases. Sept. 2025https://rarediseases.info.nih.gov/diseases/9304/cholangiocarcinoma2 US FDA website. Designating an Orphan Product: Drugs and Biological Products Sept.25 https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions/designating-orphan-product-drugs-and-biological-productsForward-Looking StatementsStatements included in this press release that are not a description of historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements about future clinical trials, results and the timing of such trials and results. Such risk factors are identified and discussed from time to time in OBI Pharma's reports and presentations, including OBI Pharma's filings with the Taiwan Securities and Futures Bureau.COMPANY CONTACT:Kevin Poulos, Chief Business OfficerOBI Pharma USA, Inc.+1 (619) 537 7698, ext. 102kpoulos@obipharma.comSOURCE: OBI Pharma USA, Inc. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

JAKARTA, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) - Indonesia's state-owned social security agency PT TASPEN (Persero) has reiterated its commitment to ensuring social protection for all Indonesian Civil Servants and State Officials, including those stationed abroad.President Director Taspen, Rony Hanityo (2nd left) delivers Work Accident Security Program benefits to the wife of the late Zetro Leonardo Purba, Junior Chancellery Officer at the Indonesian Embassy in Lima, Peru, who died while performing official duties on Sept 1, 2025.The statement follows TASPEN's recent distribution of Work Accident Security Program (Jaminan Kecelakaan Kerja/JKK) benefits to the family of the late Zetro Leonardo Purba, a Junior Chancellery Officer at the Indonesian Embassy in Lima, Peru, who died while performing official duties on September 1, 2025.TASPEN Corporate Secretary Henra expressed condolences to the bereaved family and underscored the agency's role in upholding the state's responsibility to protect civil servants serving anywhere in the world."TASPEN expresses its deepest condolences on the passing of Mr. Zetro Leonardo. The distribution of these benefits is proof that TASPEN carries out its state mandate with integrity and accountability. It is our responsibility to ensure that every civil servant's dedication — even at the farthest corners of the world — is accompanied by a sense of security for them and their families. The state's protection knows no borders," said Aprianto.As of September 30, 2025, TASPEN has provided JKK benefits to 221 heirs of Indonesian civil servants, including those serving on overseas assignments — a reflection of the government's continued commitment to the welfare of public sector workers worldwide.Comprehensive Protection for Civil Servants and FamiliesThe assistance provided to Mr. Purba's family includes Old-Age Savings Program (Tabungan Hari Tua/THT) and Work Accident Security Program benefits, such as Death Benefits/Bereavement Benefits, Death Compensation, and Funeral Benefit. In addition, Scholarship Benefit has been granted for two of his children to support their continued education — part of TASPEN's broader effort to ensure long-term family welfare.The Work Accident Security Program (JKK) forms part of Indonesia's national social protection framework for civil servants and state officials who experience work-related accidents, occupational illnesses, or death while performing state duties — whether domestically or abroad.Four Key Programs Supporting Civil ServantsTASPEN manages four major programs designed to create an integrated and sustainable social security system for civil servants:1. Old-Age Savings Program (THT): A savings and protection plan for employees nearing retirement or their families in case of death before retirement.2. Pension Program: Guarantees a regular post-retirement income as recognition of civil servants' long-term service.3. Work Accident Security Program (JKK): Covers the risk of workplace injuries, illnesses, or death occurring in the line of duty, including while serving abroad.4. Death Security Program (Jaminan Kematian/JKM): Provides compensation and educational scholarships for the families of civil servants who pass away from non-work-related causes.These programs establish a comprehensive social safety net that protects civil servants throughout their professional and personal lives. TASPEN's initiatives reflect the Indonesian government's principle that public service deserves lifelong protection — regardless of where it is carried out. By extending coverage beyond national boundaries, the TASPEN ensures that Indonesian civil servants serving on global missions receive the same level of welfare assurance as those at home.Through adaptive and accountable management, TASPEN continues to play a strategic role as a partner of the Indonesian government in strengthening the welfare and security of civil servants worldwide.About PT TASPEN (Persero)PT TASPEN (Persero) or the Civil Servant Savings and Insurance Fund is an Indonesian state-owned enterprise engaged in retirement savings insurance and pension funds for civil servants (ASN) and state officials. Established on April 17, 1963, PT TASPEN (Persero) plays an active role in social welfare, particularly for civil servants in Indonesia. PT TASPEN (Persero) currently offers several products and services, namely the Work Accident Security Program (JKK), Death Security Program (JKM), Old-Age Savings Program (THT), and Pension Program.PT TASPEN (Persero) is currently the First Chairman of the Asian Civil Service Pension Association (ACSPA), which is the first Association of Social Security Administrators for Civil Servants in Asia, with members consisting of Social Security Administrators for ASN from various countries in Asia, including Indonesia, South Korea, the Philippines, Thailand, and Cambodia. PT TASPEN (Persero) prioritizes the comfort and safety of its participants by implementing the digital superapp service Andal by TASPEN.For information, you can contact the Call Center at 1500919, visit the official website www.taspen.co.id, tcare.taspen.co.id, and all official social media accounts of PT TASPEN (Persero). Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

台北，台灣, 2025年11月17日 - (亞太商訊 via SeaPRwire.com) - 台灣浩鼎（4174.TWO）今（11/16）日宣布，接獲美國食品藥物管理局（US FDA）通知，旗下以 TROP2 為靶向的ADC新藥 OBI-902 ，已獲審核通過治療膽管癌（Cholangiocarcinoma）的「孤兒藥（Orphan Drug Designation）」資格認定。OBI-902 為浩鼎首款自主開發、採用醣位點專一性鍵結的新型 ADC。膽管癌是一種罕見且致死率高的惡性腫瘤，美國患者人數少於五萬人。依疾病分期、組織型態及發病部位不同，其五年存活率約介於2%至23%¹。目前，美國 FDA 尚未核准針對膽管癌的ADC藥物上市銷售。為鼓勵業界開發治療罕見疾病的新藥，美國 FDA 設有「孤兒藥」資格認定制度，凡具潛力的候選藥物經審核通過後即可獲得此資格認定。在美國，罕見疾病被定義為患者人數少於二十萬人的疾病。經美國 FDA 認定為「孤兒藥」後，藥物開發公司可獲得多項優惠措施，包括臨床支出稅務優惠、藥證申請費用減免，以及市場專賣保護期等²。                              浩鼎已於2025年8月在美國與台灣展開 OBI-902 一期/二期臨床試驗，招募晚期實體腫瘤患者。該試驗的目標在於驗證 OBI-902 的安全性、藥物動力學特性及初步療效。浩鼎執行長王慧君博士表示：「根據臨床前數據，OBI-902 相較於已上市或研發中的其他 TROP2 ADC，展現許多優勢，在血液循環中具高度穩定性、能對周圍未表現 TROP2 的癌細胞產生殺傷作用（旁觀者效應），同時具能克服抗藥性的潛力，在動物試驗和類器官癌症模型中，均顯現了出色的藥物活性。更重要的是，這是浩鼎首度在臨床上應用獨家專利的 GlycOBI® ADC 關鍵技術，其中包含膽管癌病人。我們期待以臨床試驗進一步證明： OBI-902成為同類最佳（best-in-class）的潛力。」About OBI-902OBI-902 是以 TROP2 為靶向的抗體藥物複合體（ADC）新藥，攜帶強效的拓撲異構酶 I 抑制劑以殺死腫瘤細胞，藥物抗體比例（Drug-Antibody Ratio, DAR）為 4。TROP2 在包括乳癌、肺癌、膽道癌（膽管癌）、卵巢癌、胃癌等多種實體瘤中均有高度表現，因而被視為癌症治療的理想靶點。OBI-902 是一款新型的醣位點專一性 ADC，採用浩鼎專利的 GlycOBI® 技術所驅動，具有良好的穩定性和親水性。在多種動物模型中，OBI-902 展現出卓越的抗腫瘤功效、出色的藥物動力學特性以及良好的安全性。其臨床試驗申請（IND）已於2025年4月30日獲美國 FDA 核准。本公司於2021年12月自博奧信生物技術公司（Biosion, Inc., www.biosion.com）授權引進 TROP2 抗體。依合約條款，博奧信保留該抗體在中國的相關權利，浩鼎則獲授權於中國以外的權利。除中國境內的抗體權利外，浩鼎擁有 OBI-902 ADC的全球商業化權利。About GlycOBI ®浩鼎開發出獨家專利的醣位點專一性ADC技術（GlycOBI®）已應用於臨床階段，其具備「隨插即用」特性，可與各類抗體、連接子（linkers）和藥物（payloads）兼容，藥物抗體比（Drug-Antibody Ratio, DAR）最高可達 16。透過自主研發的雙功能酵素 EndoSymeOBI® 與高親水性連接子技術 HYPrOBI®，可在 GMP 製程中高效率量產具均質性的 ADC。其偶聯過程避免了破壞抗體結構，並確保 ADC 具有與天然抗體相似的生物特性。另一方面，HYPrOBI® 高親水性連接子技術提升了藥物偶聯效率並降低藥物生產時不均勻結塊的風險，在 ADC 產品製程方面更具優勢。經多項動物實驗模型顯示，採用 GlycOBI® 偶聯的 ADC 在抗腫瘤活性與穩定性上優於傳統 ADC。GlycOBI®、EndoSymeOBI® 與 HYPrOBI® 為浩鼎 Obrion™ ADC 專利技術組合的一部分，另包含 ThiOBI® 與 GlycOBI DUO™。OBI-902 為首款採用浩鼎 Obrion™ ADC 關鍵技術進入臨床評估之新藥，目前已在美國與台灣進行一期/二期臨床試驗，以評估其在癌症治療中的安全性與療效。About OBI Pharma浩鼎成立於2002年，為產品已進展至臨床階段的全球癌症新藥開發公司，總部設於台灣。浩鼎與其全資子公司 OBI Pharma USA, Inc. 的使命，是致力於開發新型抗癌藥物，為具有高度醫療需求、尚未被滿足的患者提供新的治療選擇。浩鼎的研發核心聚焦於新型抗體藥物複合體（Antibody-Drug Conjugates, ADC），包括第一代半胱胺酸鍵結 TROP2 ADC OBI-992。透過專利的 ADC 關鍵技術 GlycOBI®，並結合 EndoSymeOBI® 與 HYPrOBI®，浩鼎已建立次世代 ADC 產品線，其中包含單抗 ADC：OBI-902（TROP2）、OBI-904（Nectin-4）；雙抗單藥 ADC：HER2 x TROP2；以及雙抗雙藥 ADC：cMET x HER3。為拓展 HYPrOBI® 連接子技術的應用範圍，浩鼎進一步開發新型 ThiOBI® 平台，以實現不可逆的半胱胺酸鍵結。此外，浩鼎的產品線亦包括全球首創 AKR1C3 靶向小分子前驅藥 OBI-3424，該藥物在腫瘤中高度表達的醛酮還原酶（AKR1C3）作用下，選擇性釋放強效 DNA 烷基化劑以治療癌症。更多資訊請參閱：www.obipharma.com。GlycOBI®、EndoSymeOBI®、ThiOBI® 與 HYPrOBI® 為浩鼎的註冊商標。Obrion™ 與 GlycOBI DUO™ 為申請中之商標。1 National Institute of Health for Rare Diseases. Sept. 2025https://rarediseases.info.nih.gov/diseases/9304/cholangiocarcinoma2 US FDA website. Designating an Orphan Product: Drugs and Biological Products Sept.25 https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions/designating-orphan-product-drugs-and-biological-products新聞聯絡：陳祈宏 Derek Chen公共事務處 主管| Head of Public Affairs台灣浩鼎（OBI Pharma, Inc.）M: +886-939-797-803 |T: +886-2-2655-8799 Ext. 223derekchen@obipharma.com Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

- The 15th Asian Logistics, Maritime and Aviation Conference (ALMAC) opened today under the theme “Collaboration and Growth in the New Trade Landscape”- The event brings together over 80 heavyweight speakers to explore industry trends and opportunities, driving high-quality development in logistics and supply chain management-  New thematic sessions spotlight the Middle East and Central Asia markets, with speakers sharing the latest developments and future opportunities, analysing key strategies and investment directions- John Lee, Chief Executive of the HKSAR, and Almaz Turgunbaev, Deputy Minister of Transport and Communications of the Kyrgyz Republic, attended the Special Address session on the first day of the conference. Their participation aims to deepen international exchange and cooperation, helping to further enhance Hong Kong’s position as an international shipping and aviation hub and its roles as a “superconnector” and “super value-adder”.HONG KONG, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) – The 15th Asian Logistics, Maritime and Aviation Conference (ALMAC), organised by the Hong Kong Special Administrative Region (HKSAR) Government and the Hong Kong Trade Development Council (HKTDC), opened today (17 November) and runs for two days at the Hong Kong Convention and Exhibition Centre. Under the theme “Collaboration and Growth in the New Trade Landscape”, the conference aligns with recommendations in the 15th Five-Year Plan to enhance Hong Kong’s status as an international shipping centre, and policies laid out in the Policy Address to strengthen the development of the shipping, aviation and logistics sectors in the city. As the industry’s annual flagship event, the two-day conference gathers over 80 distinguished speakers, including government officials and industry leaders, to discuss trends and opportunities and promote high-quality development in logistics and supply chain management.John Lee, Chief Executive of the HKSAR, attended the first day of the conference to deliver a Special Address. In addition, this year’s ALMAC invited Central Asian official Almaz Turgunbaev, Deputy Minister of Transport and Communications of the Kyrgyz Republic, to also deliver a Special Address.John Lee said: “The conference theme this year, ‘Collaboration and Growth in the New Trade Landscape’, is a timely response to rising geopolitical tensions and the volatile global trade policies, which present considerable challenges for our maritime, aviation and logistics industries, from route planning and shipping fleet deployment to inventory and warehouse management. Nevertheless, as the Chinese saying goes, ‘where there are challenges, there are opportunities’. Geopolitical risks can be overcome by market diversification. Increased costs related to supply chain concerns can be offset, at least partially, by technology-enabled efficiencies.”Mr Lee also shared: “I am particularly pleased to announce that Hong Kong has established Partner Port relationships with Guangxi port and Dalian port in the Chinese Mainland, and Port San Antonio in Chile. These ports are of strategic importance, and true to our character and policy priorities. As an international maritime centre, we connect the Chinese Mainland with the world and seek partners who support an open, international trade order.”In her welcome remarks, Sophia Chong, Executive Director of the HKTDC, said: “Now is the perfect time to embrace new possibilities, as trade networks and supply chains around the world undergo a sweeping transformation. The ever-changing trade polices of major economies continue to keep business agile. At the same time, the world is being rapidly reshaped by technological advances – particularly the digitalisation of trade – and a growing industry-wide commitment to sustainability.  Hong Kong, as a major hub for aviation, shipping, logistics and supply chain management, is at the forefront of these changes. The HKTDC remains committed to leveraging the city’s unique strengths to help businesses establish resilient and sustainable supply chains, while reinforcing Hong Kong’s role as a superconnector and super value-adder.”Strengthening Hong Kong’s logistics hub role and promoting regional cooperationRecommendations in the 15th Five-Year Plan to support the consolidation and enhancement of Hong Kong’s status as an international shipping centre carry profound strategic significance. The HKTDC will continue to deepen Hong Kong’s role as an international exchange platform, facilitating connections and substantive cooperation between local and overseas industries, assisting enterprises in “going global”, helping to expand their businesses in global markets, and enhancing their competitiveness. A key focus is promoting trade linkages and actively encouraging enterprises to leverage the HKTDC’s trade platforms and events to achieve greater cooperation across industries. This year’s ALMAC continues to feature business-matching sessions, connecting shippers with service providers to foster regional partnerships and drive industry growth.ALMAC this year features exhibition zones dedicated to aviation, the low-altitude economy, technology, supply chain management and logistics services as well as maritime and port services. Over 90 exhibitors are showcasing the latest leading logistics and supply chain solutions. Notably, the Low-altitude Economy zone makes its debut at ALMAC, with enterprises from the Regulatory Sandbox pilot projects – including SF Express (Hong Kong) and Esri China (Hong Kong) Limited –demonstrating cutting-edge technologies and applications in drones, unmanned aerial vehicles (UAVs) and urban air mobility (UAM), promoting awareness of the latest innovations and applications in this fast-rising sector.Three key trends in focus; unlocking opportunities in the Middle East and Central AsiaThis year’s ALMAC focuses on three key trends: supply chain diversification, sustainability and green energy and innovation and technology, highlighting Hong Kong’s critical role in global connectivity.On the first day, the key session “Insights into a New Era of Global Trade: Driving Business Growth” will feature international industry leaders from SEKO Logistics, GEODIS, and Mattel who will explore the challenges and opportunities arising from changes in trade policies and economic fragmentation. Newly launched thematic sessions will focus on the potential of the Middle Eastern and Central Asian markets. In the Middle East Session, representatives from Etihad Airways, DP World Logistics and the Qatar Free Zones Authority will share insights on logistics innovation and investment strategies. The Central Asia Session will engage representatives from QazTrade Center for Trade Policy Development, JSC, under the Ministry of Trade and Integration of the Republic of Kazakhstan, Shyngar Trans Logistics Company, the Organisation for Economic Co-Operation and Development and PTC. The discussion will address regional supply chain development and the advantages of multimodal transport.Low-altitude economy and smart ports: reshaping the air and maritime transport landscapeIn the first-day session “The Engine of Low-altitude Economy: How Cargo Drones Are Revolutionising the Future of Air Logistics”, Manal Habib, CEO and Founder, MightyFly; Bobby Healy, CEO and Founder, Manna; Kenny Lau, Chief Technology Officer, SF Express (Hong Kong) Limited; Ryan Walsh, Founder and CEO, Valqari; and Andrea Wu, CEO, Urban-Air Port Ltd, shared the latest breakthroughs in drone freight design, automation and AI-driven logistics systems. Meanwhile, the Low-altitude Economy zone at the conference is showcasing drones and related applications, allowing participants to experience first hand the future of air transport and explore the potential of low-altitude economy innovations in the logistics sector.In addition, the Port Community System X LSCM Maritime Summit 2025 will focus on the future development of smart ports and smart trade. The summit will explore how applying the Port Community System (PCS) can significantly enhance operational efficiency and supply chain visibility through cutting-edge technologies such as AI, blockchain and the Internet of Things. It will also showcase Hong Kong’s unique advantages as an international shipping centre and a hub for smart trade. Conference and workshops support enterprises’ green transformationA first-day workshop, “Sustainable Finance: Navigating a Sustainable Future across Logistics, Shipping, and Aviation Industries”, focused on how ESG (environmental, social and governance) is reshaping operational models and development directions in the logistics, maritime and aviation sectors. Patrick Lau, Deputy Executive Director of the HKTDC, gave the Opening Address at the workshop, followed by industry experts including KT Ting, Chief Operating Officer, Hong Kong Quality Assurance Agency; Calvin Chung, Director, Chimbusco Pan Nation; Wai Yeung Tam, Senior Finance Manager, SF REIT Asset Management Limited; and Eric Liu, Chief Executive, Cathay United Bank Hong Kong Branch. They discussed challenges and opportunities in the industry’s green transformation and addressed the important role of sustainable finance to support enterprises in the transition.As the world strives towards net-zero emissions, Hong Kong is committed to developing as a green maritime centre. The recent Policy Address proposes establishing Hong Kong as a green marine fuel bunkering centre, focusing on green methanol, green ammonia and hydrogen. A session titled “Green Energy Forum: Fuels, Freight, and the Road to Net Zero” will be held tomorrow (18 November) to share pathways, challenges and opportunities for a more sustainable and low-carbon future. Speakers include Essam Al Sheibany, Vice President Sustainability, Asyad Group; Tryggvi Thor Herbertsson, Head of Hydrogen Strategy and Partnership, Qair Group; James Laybourn, Regional Segment Director, APAC, DNV Energy Systems; and Wu Yi, Deputy General Manager, Kunlun Energy Co., Ltd.ALMAC offers a rich and diverse programme for participants, with tomorrow’s highlighted sessions, including the Hong Kong Authorized Economic Operator (AEO) Programme, the Supply Chain Management and Logistics Panel, “Logtech Forum: Stay Ahead in the Next Wave of Supply Chain Innovation”, and the Youth Empowerment Workshop. Representatives from companies such as HP, Reckitt, DHL Express, LALAMOVE and Procter & Gamble will share valuable insights and practical skills, helping participants stay ahead of the latest industry developments.The 15th Asian Logistics, Maritime and Aviation ConferenceDate17 and 18 November 2025 (Monday and Tuesday)VenueHall 3FG, HKCECWebsitesALMAC: https://almac.hktdc.com/conference/almac/enProgramme: https://almac.hktdc.com/conference/almac/en/programmeSpeaker list: https://almac.hktdc.com/conference/almac/en/speakerPhoto download: https://bit.ly/4ojiKsFThe 15th Asian Logistics, Maritime and Aviation Conference (ALMAC), organised by the HKSAR Government and the HKTDC, opened today. Under the theme “Collaboration and Growth in the New Trade Landscape”, the event brings over 80 heavyweight speakers to explore industry trends and opportunitiesJohn Lee, Chief Executive of the HKSAR, attended the first day of the conference to deliver a Special AddressSophia Chong, Executive Director of the HKTDC, delivered welcome remarks at the Opening SessionBusiness-matching sessions at ALMAC are connecting shippers with service providers to foster regional partnerships and drive industry growthThe Low-altitude Economy zone made its debut at this year’s ALMAC Exhibition, demonstrating cutting-edge technologies and applications in drones, unmanned aerial vehicles and urban air mobilityThe session titled “Steering Business Growth in a New Era of Global Trade” explored the ripple effects of evolving trade policies and the impact of rising economic fragmentationIn the session “Tapping the Middle East: Logistics, Innovation & Trade Potentials”, industry leaders from the Middle East shared the huge opportunities and transformation potential in logistics and supply chainsMedia enquiriesYuan Tung Financial Relations:Louise SongTel: (852) 3428 5690Email: lsong@yuantung.com.hkTiffany LeungTel: (852) 3428 2361Email: tleung@yuantung.com.hkHKTDC’s Communications & Public Affairs Department:Johnny TsuiTel: (852) 2584 4395Email: johnny.cy.tsui@hktdc.orgClayton LauwTel: (852) 2584 4472Email: clayton.y.lauw@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus.  Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

The updated study incorporates redesigned dry-stack tailings system engineered to eliminate acid mine drainage and is one of the final ESIA reports.Ottawa, Ontario--(ACN Newswire via SeaPRwire.com - November 17, 2025) - Focus Graphite Inc. (TSXV: FMS) (OTCQB: FCSMF) (FSE: FKC0) ("Focus" or the "Company"), a leading Canadian graphite developer advancing high-grade projects, is pleased to announce that it has commissioned an updated Air Dispersion Modelling and Dust Management Study (the "Study") for its 100%-wholly owned Lac Knife Project (the "Project") in Quebec. This work represents one of the final environmental studies required to complete the Environmental and Social Impact Assessment ("ESIA") and advance the Project toward mine-permitting readiness.The Study will be led by WSP Canada Inc. ("WSP"), a world-leading Montreal-based global engineering, environmental, and professional-services consultancy, and will be conducted under the supervision and management of IOS Geosciences Inc. ("IOS"), the Company's geological consultant and general contractor for the Project. WSP includes the former Woods Engineering, which participated in the 2019 preliminary design of the dry-stack tailings storage facility ("TSF"), as well as Golder Inc., which conducted the original 2014 Study.The Study will evaluate the potential airborne dispersion of dust and gases associated with mining operations, including:wind-driven erosion from the TSF,emissions generated by blasting activities, andtraffic-related dust along the 7-kilometre access road linking Lac Knife to Highway 389.This updated modelling replaces the earlier 2014 study to reflect the re-engineered dry-stack tailings design, developed as part of the 2021 Feasibility Study (the "Feasibility") update. The redesign eliminates the former wet-pond configuration and instead utilizes dolomitic marble to amend and encapsulate tailings, thereby preventing acid mind drainage ("AMD") and metal leaching. This new TSF concept was considered material enough to necessitate remodelling of the areal dispersion.The current program directly addresses follow-up questions from Quebec's Ministry of Sustainable Development, Environment, and the Fight Against Climate Change ("MDDELCC"), issued during its review of the Company's 2014 ESIA submission. Results from the Study are expected by February 2026, aligning with the planned submission of the final revised ESIA."The completion of the air dispersion modelling and dust management plan marks one of the last major technical steps in our environmental review process," said Dean Hanisch, Chief Executive Officer of Focus Graphite. "We are now systematically finalizing outstanding ESIA components to move Lac Knife toward the permitting stage. Each of these studies reflects our ongoing commitment to advance the Project responsibly."Qualified PersonThe technical content disclosed in this news release was reviewed and approved by Rejean Girard, P.Geo. (QC), President of IOS Geosciences Inc., a consultant to the Company, and a qualified person as defined under National Instrument NI-43-101.About WSP Canada Inc.WSP Canada Inc. is a Canadian subsidiary of WSP Global Inc., one of the world's leading professional-services firms. Headquartered in Montreal, Quebec, WSP provides multidisciplinary engineering, environmental, and consulting services across the infrastructure, energy, mining, transportation, and built-environment sectors. With thousands of professionals across Canada and internationally, WSP delivers technical excellence and sustainable solutions supporting clients through every stage of project development.For more information on WSP Canada Inc. please visit https://www.wsp.com/en-ca/ About Focus Graphite Advanced Materials Inc. Focus Graphite Advanced Materials is redefining the future of critical minerals with two 100% owned world-class graphite projects and cutting-edge battery technology. Focus Graphite's flagship Lac Knife project stands as one of the most advanced high-purity graphite deposits in North America, with a fully completed feasibility study. Lac Knife is set to become a key supplier for the battery, defense, and advanced materials industries.Focus Graphite's Lac Tetepisca project further strengthens our portfolio, with the potential to be one of the largest and highest-purity and grade graphite deposits in North America. At Focus, they go beyond mining – we are pioneering environmentally sustainable processing solutions and innovative battery technologies, including our patent-pending silicon-enhanced spheroidized graphite, designed to enhance battery performance and efficiency.Focus Graphite's commitment to innovation ensures a chemical-free, eco-friendly supply chain from mine to market. Collaboration is at the core of our vision. We actively partner with industry leaders, research institutions, and government agencies to accelerate the commercialization of next-generation graphite materials. As a North American company, we are dedicated to securing a resilient, locally sourced supply of critical minerals – reducing dependence on foreign-controlled markets and driving the transition to a sustainable future.For more information on Focus Graphite Inc. please visit http://www.focusgraphite.comLinkedIn: https://www.linkedin.com/company/focus-graphite/ X: https://x.com/focusgraphiteInvestors Contact: Dean Hanisch CEO, Focus Graphite Inc. dhanisch@focusgraphite.com +1 (613) 612-6060Jason LatkowcerVP Corporate Developmentjlatkowcer@focusgraphite.comCautionary Note Regarding Forward-Looking StatementsCertain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could," "intend," "expect," "believe," "will," "projected," "estimated," and similar expressions, as well as statements relating to matters that are not historical facts, are intended to identify forward-looking information and are based on the Company's current beliefs or assumptions as to the outcome and timing of such future events.In particular, this press release contains forward-looking information regarding, among other things, the anticipated timing, scope, and results of the Air Dispersion Modelling and Dust Management Study (the "Study") at the Lac Knife Project; the completion of the Company's Environmental and Social Impact Assessment ("ESIA") and related technical studies, including hydrogeological and tailings dam analyses; the expected timing of regulatory submissions and approvals; the potential for the Project to achieve mine-permitting readiness; and the advancement of the Lac Knife Project toward development. Forward-looking information also includes statements regarding the Company's expectations concerning the effectiveness of the redesigned dry-stack tailings storage facility, the ability to meet Québec's environmental and regulatory standards, the anticipated role of the Lac Knife and Lac Tetepisca projects within Canada's Critical Minerals Strategy, and the Company's capacity to secure the financing and partnerships required to advance these projects responsibly and sustainably.Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, risks related to market conditions, regulatory approvals, changes in economic conditions, the ability to raise sufficient funds on acceptable terms or at all, operational risks associated with mineral exploration and development, and other risks detailed from time to time in the Company's public disclosure documents available under its profile on SEDAR+.The forward-looking information contained in this release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties, and assumptions contained herein, investors should not place undue reliance on forward-looking information.Neither TSX Venture Exchange nor its Regulation Services accepts responsibility for the adequacy or accuracy of this release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274738 Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) – iRad Hospital, the pioneering resort medical facility located at Studio City, today announced the signing of a cooperation agreement with Hong Kong Sanatorium & Hospital. This partnership launches comprehensive cross-border medical concierge services, reinforcing the Macau government's "1+4" moderate economic diversification framework and supporting Macau's emergence as a medical tourism destination.This strategic alliance enables seamless connectivity of medical services between the two regions, providing patients with access to expanded specialty medical resources through iRad's medical concierge platform.Combining Hong Kong Sanatorium & Hospital's 103-year legacy of comprehensive medical excellence with iRad's over 20 years of professional medical experience and resort-integrated healthcare model, this partnership establishes an unprecedented healthcare network covering the Pearl River Delta region.The medical concierge program facilitates integrated care coordination, efficient cross-institutional scheduling, and personalized treatment plans utilizing resources from both institutions. This comprehensive approach ensures seamless continuity of care, delivering better clinical outcomes for patients seeking medical services in the region.Mr. Lawrence Ho, Founder of Black Spade Capital and Chairman & CEO of Melco, stated, "The collaboration between iRad and Hong Kong Sanatorium & Hospital demonstrates our commitment to advancing Macau's '1+4' industrial transformation agenda, creating vital healthcare connections between the two regions, enriching Studio City's health tourism offerings while expanding healthcare options for the Greater Bay Area community."Mr. Wyman Li, Chief Operating Officer of HKSH Medical Group, remarked, "Partnering with iRad reflects our vision of borderless healthcare, bringing exceptional value to patients in both markets, developing new approaches for the Greater Bay Area, and further deepening collaborative innovation across various sectors within the region."Photo caption: (From left to right) HKSH Head of Business Development Mr. Wei-Hsu Chen, iRad Hospital Founder & Chairman Dr. Matthew Ngan, HKSH Medical Group Chief Operating Officer Mr. Wyman Li, Black Spade Capital Founder and Melco Chairman & CEO Mr. Lawrence Ho, Black Spade Capital CEO and iRad Hospital Honorary Chairman Mr. Dennis Tam, HKSH Assistant Medical Superintendent Dr. Lau Chor Chiu, and iRad Hospital CEO Mr. Kin Wong celebrate the strategic partnership between iRad Hospital and Hong Kong Sanatorium & Hospital.About HKSH Medical GroupOfficially launched in September 2017, HKSH Medical Group promotes public health and advanced medicine through a multi-faceted, coordinated approach across clinical services, medical education, scientific research and public health education. Members of the Group, including Hong Kong Sanatorium & Hospital, HKSH Healthcare and HKSH Eastern Medical Centre, are dedicated to offering top-quality holistic care to patients, upholding the motto “Quality in Service, Excellence in Care.”Hong Kong Sanatorium & Hospital is a key member of HKSH Medical Group. Established in 1922, it is one of the leading private hospitals in Hong Kong. Living up to its motto of “Quality in Service Excellence in Care,” the Hospital is committed to serving the public as well as promoting medical education and research.For more information about HKSH Medical Group, please visit www.hksh.com.About iRad Medical Group—Hong Kong's Largest MRI Diagnostic Service ProviderEstablished in 2005, iRad is a trusted leader in diagnostic radiology across Hong Kong. Black Spade Capital has been iRad Medical's controlling shareholder since 2021. As at 2024, iRad was the largest MRI diagnostic services provider in Hong Kong by revenue and by the number of MRI scanners. Focused on delivering high-quality imaging services and exceptional patient care, the Group's strong and extensive client base includes the Government of the Hong Kong SAR, as well as other high-profile medical groups, corporations, private doctors and NGOs. Meanwhile, iRad Hospital is the first and largest private medical imaging and examination service provider within an integrated resort in Macau, making iRad Group the first medical imaging group in the world to offer comprehensive private imaging and examination services, including MRI and CT services, to the integrated resort industry.Media Enquiries:Strategic Financial Relations LimitedVicky LeeTel: +852 2864 4834Email: vicky.lee@sprg.com.hk Iris Au YeungTel: +852 2114 4913Email: iris.auyeung@sprg.com.hkWebsite: www.sprg.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2025年11月17日 - (亞太商訊 via SeaPRwire.com) - 位於新濠影滙的開創性度假村醫療設施卓智醫院（iRad），今日宣布與香港養和醫院簽訂合作協議。此次合作推出全方位跨境醫療禮賓服務，強化澳門政府「1+4」產業適度多元發展框架，助力澳門成為新興醫療旅遊目的地。這項戰略聯盟實現兩地醫療服務的無縫連接，透過iRad的醫療禮賓平台為患者提供更多專科醫療資源。結合香港養和醫院103年深厚的綜合醫療傳承與iRad逾20年的專業醫療經驗及度假村融合醫療模式，此夥伴關係建立起覆蓋珠江三角洲地區前所未有的醫療網絡。醫療禮賓計劃促進綜合護理協調、跨機構高效排程，以及運用雙方機構資源制定的個人化治療方案。這種全面的方式確保護理服務的無縫銜接，為區內尋求醫療服務的患者帶來更佳的臨床效果。黑桃資本創辦人及新濠主席兼行政總裁何猷龍先生表示：「iRad與香港養和醫院的合作展現我們推進澳門『1+4』產業轉型議程的承諾，在兩地之間創建重要的醫療連結，豐富新濠影滙的健康旅遊內容，同時擴展大灣區社區的醫療選擇。」養和醫療集團營運總監李維文先生表示：「與iRad合作反映我們無界限醫療的願景，為兩地市場的患者帶來卓越價值，為大灣區發展新思路，進一步深化灣區內各領域間合作創新。」圖片說明：（左起）香港養和醫院業務拓展主管陳威旭先生、卓智醫院創辦人兼主席顏文煌醫生、養和醫療集團營運總監李維文先生、黑桃資本創辦人及新濠主席兼行政總裁何猷龍先生、黑桃資本行政總裁及卓智醫院榮譽主席譚志偉先生、香港養和醫院副院長劉楚釗醫生，以及卓智醫院首席執行官黃建豐先生，共同慶祝卓智醫院與香港養和醫院達成戰略夥伴關係。關於養和醫療集團養和醫療集團於 2017 年 9 月正式啟動，旗下成員分別有養和醫院、養和醫健、養和東區醫療中心及養和癌症中心。養和醫療集團以全方位策略，透過優質臨床醫療服務、醫學教育和科研，以及公眾健康教育，推動公共衞生及醫學發展，致力為患者提供全人關顧的優質醫療及護理服務。養和醫院是養和醫療集團之重要成員，成立於 1922 年，為香港主要私營醫院之一，以「優質服務‧卓越護理」為宗旨，致力服務大眾，並積極推動醫學教育和研究。關於養和醫療集團，請瀏覽www.hksh.com.關於卓智醫療集團—香港最大的磁力共振診斷服務供應商卓智醫療成立於2005年，是香港放射診斷領域規模領先的醫療集團。黑桃資本自2021年起成為卓智醫療的控股股東。截至2024年，卓智醫療集團憑藉營業收入及磁力共振掃描儀數量，成為香港規模最大的磁力共振診斷服務供應商。集團致力提供優質的醫學掃描診斷服務及卓越的病人護理，擁有廣泛且穩固的客戶基礎，包括香港特別行政區政府、知名保險公司、具影響力的醫療團體、企業、私人醫生和非政府組織。與此同時，卓智醫院作為澳門綜合度假村內首家且規模最大的私人醫學影像與檢查服務供應商，使卓智集團成為全球首個為綜合度假村產業提供全面私人影像及檢查服務（包括磁力共振與電腦斷層掃描服務）的醫學影像集團。傳媒垂詢：縱橫財經公關顧問有限公司李惠兒電話：+852 2864 4834電郵：vicky.lee@sprg.com.hk 歐陽蔚雯電話：+852 2114 4913電郵：iris.auyeung@sprg.com.hk網址：www.sprg.com.hk Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) – Coinciding with Hong Kong FinTech Week and StartmeupHK Festival, held from November 3 to 7 featuring a series of annual events, the Payment Card Group Limited (“PCG”), a cloud-native payment processor and acquirer, demonstrated its comprehensive business strategy. On November 7, PCG presented its stablecoin settlement pilot program at the Cyberport Venture Capital Forum 2025 (CVCF), demonstrating a technological breakthrough in achieving 5-second cross-border settlement. Additionally, PCG co-organized a forum with the Hong Kong Digital Finance Association (HKDiFi) and shared industry insights on the evolving role of responsible officers. In terms of business development, PCG’s members, Yedpay and BBMSL, have partnered with Visa to launch the “China-Issued Visa Credit Card Instant Discount Program,” helping local merchants expand their mainland customer base. Meanwhile, PCG has continued to promote its “AbbyPay” POS-free digital payment solution at an exchange event with Chiyu Bank and various industry events, driving deeper integration between traditional finance and innovative technology, and demonstrating its forward-looking strategy and industry influence within the digital finance ecosystem.Showcasing stablecoin settlement pilot program at Cyberport Venture Capital Forum 2025On November 7, PCG showcased its latest projects and technological achievements at the Cyberport Venture Capital Forum 2025 (CVCF), including the stablecoin settlement pilot program and the “AbbyPay” POS-free digital payment solution. As the only payment technology company selected in the “Payment & Stablecoin” category under Cyberport’s “Blockchain & Digital Asset Pilot Subsidy Scheme,” PCG launched a stablecoin settlement pilot program with the vision of bridging traditional card payments with Web3 infrastructure. The pilot simulated an Australia-to-Hong Kong transaction using stablecoins within a controlled test environment. Compared to traditional settlement that takes 2 to 3 days and involves high FX and SWIFT costs, stablecoin settlement can be completed under 5 seconds, at 90% lower cost, with on-chain transparency. This solution enables real-time reconciliation, programmable payouts, and cross-border scalability, fully demonstrating the potential of stablecoins to enhance the payment infrastructure.Mr. Michael Hui, Regional Product Director of PCG, stated during the Cyberport’s Blockchain & Digital Asset Pilot Subsidy Scheme use case-sharing session, “With Hong Kong’s Stablecoins Ordinance now in effect, we welcome and support this forward-looking regulatory framework. Thanks to Cyberport, JETCO, our advisors, and industry partners, our pilot program has demonstrated how traditional card payments and Web3 infrastructure can truly come together, achieving stable, efficient, and compliant settlement through blockchain. Looking ahead, we will extend the pilot with merchants across various industries and continue to collaborate with banks, acquirers, and fintech companies to advance industry dialogue and scale adoption, enabling merchants to enjoy faster, more cost-effective, and transparent cross-border payment collections. We believe that with regulated stablecoins, strong compliance, and industry collaboration, Hong Kong is poised to lead the next chapter of digital settlement innovation.”Mr. Michael Hui, Regional Product Director of PCG introduces PCG’s stablecoin settlement pilot program during the Cyberport’s Blockchain & Digital Asset Pilot Subsidy Scheme use case-sharing session.Additionally, Mr. Emil Chan, Advisor of PCG, stated at the panel discussion themed “Stablecoin from a User Perspective: Unlocking New Business Opportunities”, “Stablecoins can bring revolutionary changes to cross-border payments, significantly reducing transaction fees and settlement period. They also enhance financial inclusion, enabling anyone with a smartphone to safely and efficiently access the global market. For merchants, the advantages of stablecoin adoption such as lower fees, instant settlement, and no chargebacks for fraud prevention, can help improve cash flow and attract new customers.”During the panel discussion themed “Stablecoin from a User Perspective: Unlocking New Business Opportunities,” Mr. Emil Chan, Advisor of PCG shares how stablecoins can empower merchants and drive industry transformation.Co-hosting “The New Frontier: ROs as Catalysts for Digital Finance Ecosystems” Forum with Hong Kong Digital Finance AssociationOn the same day, PCG and the Hong Kong Digital Finance Association (HKDiFi) co-hosted an official side event of Hong Kong FinTech Week 2025, “The New Frontier: ROs as Catalysts for Digital Finance Ecosystems” Forum, exploring the new role of responsible officers (ROs) in driving business growth in an increasingly regulated environment. Prof. Emil Chan, Advisor of PCG, and Chairman of the Association of Cloud and Mobile Computing Professionals, remarked, "During PCG's stablecoin settlement research and development process, we witnessed a transformation in the role of ROs. They have evolved from mere compliance gatekeepers into key forces driving innovation. They proactively seek new avenues for innovation, establish frameworks for risk management, build trust with relevant institutions, and set the stage for project success. This shift demonstrates that ROs play a pivotal role in driving success for traditional finance in the digital era."At the Forum, Prof. Emil Chan, Advisor of PCG, and Chairman of the Association of Cloud and Mobile Computing Professionals, Dr. Kenny Siu, Training Director of ESG Academy, Dr. Raymond Chan, Vice Chairman of HKDiFi, and Dr. Hermann Lui, Program Director of Investopedia Institute of Hong Kong, analyze how ROs can redefine their roles to drive business growth.Dialogue with Chiyu Bank senior executives on Hong Kong's digital finance outlookOn October 23, PCG was honored to be invited by the Hong Kong Productivity Council (HKPC) to jointly host senior executives from Chiyu Bank as part of their executive development program centered on “Leadership in Transformation.” Mr. Emil Chan, Advisor of PCG, shared valuable insights on “Opportunities and Challenges in Hong Kong’s Digital Financial Market.” Additionally, PCG team introduced the latest “AbbyPay” POS-free digital payment solution, demonstrating its innovative breakthrough in payment technology. During the event, both parties not only explored the evolving payments landscape in Hong Kong, but also fostered in-depth exchanges between traditional banking expertise and fintech innovation through cross-industry dialogues, driving continuous industry innovation.PCG team engages in a dialogue with Chiyu Bank senior executives to explore the future of digital finance in Hong Kong.Partnering with Visa to help local merchants expand mainland customer baseRecently, PCG members, Yedpay and BBMSL, have partnered with Visa to launch the "China-Issued Visa Credit Card Instant Discount Program." From now until December 31, 2025, China Construction Bank Visa cardholders can enjoy an 8% instant discount on purchases of HK$500 or more at designated stores. Through this initiative, Yedpay and BBMSL aim to help Hong Kong merchants capitalize on the peak shopping season, precisely target high-quality mainland customer segments, and further expand into the mainland market.Yedpay and BBMSL, in partnership with Visa, launch the “China-Issued Visa Credit Card Instant Discount Program” to help Hong Kong merchants capitalize on the peak shopping season and expand their reach into the mainland market."AbbyPay" POS-free digital payment solution receives widespread industry recognitionSince its launch in September, PCG has actively showcased its innovative "AbbyPay" POS-free digital payment solution at various events. In October, PCG introduced "AbbyPay" to investors, industry leaders, and retail technology professionals at the Hong Kong Retail Technology Industry Association's 22nd Anniversary Annual Dinner and the Investment Projects and Talent Matching Fair of the 9th Global Greater Bay Area Sustainable Development Economic and Trade Summit, highlighting how its SoftPOS technology helps eliminate traditional hardware and provide a more convenient and secure payment solution. The enthusiastic response and strong endorsement from participants underscored the solution’s innovative qualities and practical benefits, reinforcing "AbbyPay's" potential in driving industry digital transformation.PCG introduces "AbbyPay" POS-free digital payment solution at the Hong Kong Retail Technology Industry Association's 22nd Anniversary Annual Dinner and the 9th Global Greater Bay Area Sustainable Development Economic and Trade Summit, receiving widespread industry recognition.About The Payment Cards GroupThe Payment Cards Group Limited (“PCG”) is an innovative and leading payment technology company with operations in Hong Kong, Singapore, and the Asia-Pacific region. Established in 2016, PCG has become an acquirer with principal memberships in all major card schemes and e-wallet networks. Yedpay, a member of PCG, has firmly established itself as a digital payment acceptance business in Hong Kong. Meanwhile, A3A, another member of PCG, has developed a cloud-native payment processing platform that operates through RESTful APIs, significantly reducing costs and streamlining complex processes while providing users with real-time transaction data and insights. Furthermore, BBMSL, a core member of PCG, is a payment facilitator, dedicated to offering comprehensive digital payment solutions to Hong Kong’s small and medium-sized enterprises. As an acquiring processor, PCG serves as the backbone infrastructure of the entire payment industry by its Asia’s 1st cloud-based processing and settlement platform. Rooted in Hong Kong with a global vison, PCG seeks to empower merchants with cutting-edge payment technology solutions and drive high-quality development in the global payment ecosystem.For media enquiries, please contact:AJA (IR & Communications)Avy YuTel: (852) 9500 4443Email: avy.yu@ajacapital.com.hk / info@ajacapital.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2025年11月17日 - (亞太商訊 via SeaPRwire.com) - 適逢香港金融科技周及StartmeupHK創業節於11月3日至7日舉行一系列年度活動，金融雲支付處理及收單機構交易寶有限公司（「交易寶」或「PCG」）在本屆盛會中展現全方位佈局。11月7日，PCG於「2025數碼港創業投資論壇」（Cyberport Venture Capital Forum, CVCF）展示穩定幣結算先導計劃，實現5秒跨境結算的技術革新；更聯合香港數字金融協會主辦論壇，分享對負責人員角色演變的行業洞察。在業務拓展方面，PCG旗下成員Yedpay及BBMSL與Visa合作推出「中國大陸Visa信用卡立減優惠」計劃，助力本地商戶拓展內地客源。此外，PCG近期亦透過與集友銀行的交流活動及多個業界活動中推廣「AbbyPay」免POS終端電子收款方案，持續推動傳統金融與創新科技的深度融合，彰顯其在數字金融生態系統中的前瞻佈局與行業影響力。於2025數碼港創業投資論壇展示穩定幣結算先導計劃11月7日，PCG於「2025數碼港創業投資論壇」（Cyberport Venture Capital Forum, CVCF）展示了旗下最新項目及技術成果，包括穩定幣結算先導計劃及「AbbyPay」免POS終端電子收款方案。作為數碼港「區塊鏈與數字資產試點資助計劃」中「支付及穩定幣」類別的唯一支付科技公司，PCG以融合傳統卡支付體系與Web3基礎設施為願景，開展了穩定幣結算的先導計劃，在可控環境下模擬以穩定幣進行澳洲至香港跨境交易。與需耗時2至3天、且涉及高昂外匯與SWIFT費用的傳統結算方式相比，穩定幣結算可於5秒內完成，成本降低達九成，並透過區塊鏈提高交易的透明度。該方案可實現即時對賬、可編程支付以及跨境擴展，充分展現了穩定幣推動支付基礎設施升級的潛力。PCG區域產品總監許宇濤先生於數碼港「區塊鏈與數字資產試點資助計劃」案例分享環節中表示：「我們對香港《穩定幣條例》這項前瞻性的監管框架落地表示歡迎與支持。在數碼港、銀通（JETCO）、顧問團隊和業界夥伴的支持下，我們的先導計劃驗證了傳統卡支付體系與Web3基礎設施的深度融合，透過區塊鏈實現穩定、高效與合規結算。展望未來，我們將與更多不同業界的商戶擴展試點，並持續攜手銀行、收單機構及金融科技企業，推動行業交流及規模化應用，為商戶帶來更快捷、更實惠、更透明的跨境收款體驗。我們相信，隨著穩定幣監管落地、合規體系完善及行業協作深化，香港有望引領數字結算創新的新篇章。」PCG區域產品總監許宇濤先生於數碼港「區塊鏈與數字資產試點資助計劃」案例分享環節，介紹PCG穩定幣結算先導計劃。此外，PCG顧問陳家豪先生於「用戶視角下的穩定幣：激發無限商機」專題討論中表示：「穩定幣可為跨境支付帶來革命性改變，不僅能大幅降低手續費及結算時間，更能提升金融普惠性，讓任何擁有智能手機的用戶都能安全、高效地參與全球市場。對商戶而言，穩定幣支付在成本、實時結算和防退款欺詐等方面的優勢，有助改善資金流動並吸引新客群。」PCG顧問陳家豪先生於「用戶視角下的穩定幣：激發無限商機」專題討論，分享穩定幣如何賦能商戶，推動產業變革。攜手香港數字金融協會合辦「RO的創世紀：建構數字金融新生態，引爆商機」論壇同日，PCG與香港數字金融協會聯合舉辦了香港金融科技周 2025 官方會外活動 ──「RO的創世紀：建構數字金融新生態，引爆商機」論壇，深度剖析負責人員（Responsible Officers, RO）在監管日益完善的環境下如何轉型為業務增長推動者。PCG顧問、雲端與流動運算專業人士協會會長陳家豪教授表示：「 PCG在開展穩定幣結算研發過程中，見證了負責人員（RO）角色的演變。他們不再只是合規守門員，更是推動創新的引擎。他們主動為創新尋找出路、為風險建立框架，並與相關機構建立信任，引導項目奠定基礎。這證明了RO是傳統金融在數字時代取得成功的關鍵驅動力。」PCG顧問、雲端與流動運算專業人士協會會長陳家豪教授、ESG Academy 培訓總監邵志堯博士、香港數字金融協會副會長陳頴峯博士及香港投資商學院課程總監呂日朗博士於論壇上，深度剖析RO如何轉型推動業務增長。與集友銀行集團高級管理團隊對話，探討香港數字金融未來10月23日，PCG有幸獲香港生產力促進局邀請，聯合接待集友銀行的高級管理團隊，參與其以「變革中的領導力」為主題的高管培訓計劃。PCG顧問陳家豪先生以「香港數字金融市場的機遇與挑戰」為主題，分享了對香港數字金融發展的寶貴見解。此外，PCG團隊於活動上介紹了最新的「AbbyPay」免POS終端電子收款方案，展現了其在支付技術領域上的創新突破。雙方在本次活動中不僅深入探討香港支付生態的發展趨勢，更透過跨業界對話，促進傳統銀行專業與金融科技創新的深度交流，推動行業持續創新。PCG團隊與集友銀行高級管理團隊對話，探討香港數字金融未來。攜手Visa助力本地商戶開拓內地客源近日，PCG旗下成員Yedpay及BBMSL聯同Visa 推出「中國大陸Visa信用卡立減優惠」計劃。由即日起至2025年12月31日，中國建設銀行Visa信用卡持卡人到指定店舖消費滿HK$500，即享92折優惠。Yedpay及BBMSL期望透過本次活動，協助香港商戶把握消費旺季商機，精準觸達內地優質客群，進一步開拓內地市場。Yedpay及 BBMSL聯同Visa 推出「中國大陸Visa信用卡立減優惠」計劃， 助力香港商戶把握消費旺季商機及開拓內地市場。「AbbyPay」免POS終端電子收款方案獲業界廣泛認可自今年9月首次發佈「AbbyPay」免POS終端電子收款方案以來，PCG積極於各大活動中推廣與展示創新成果。今年10月，PCG先後於香港零售科技商會22周年晚宴及「第9屆環球大灣區可持續發展經貿高峰論壇」的「投資人才對接會」中，向投資者、業界領袖及零售科技專業人士等分享「AbbyPay」SoftPOS 技術如何協助商戶突破傳統硬件限制，提供更便捷、更安全的收款方案。現場反應熱烈，參與者對方案的創新與實用性予以高度評價，進一步印證「AbbyPay」在推動行業數碼轉型的潛力。PCG於香港零售科技商會22周年晚宴及「第9屆環球大灣區可持續發展經貿高峰論壇」推廣「AbbyPay」免POS終端電子收款方案，並獲業界廣泛認可。關於交易寶有限公司交易寶有限公司（「交易寶」或「PCG」）是一家創新且領先的支付科技公司，業務遍及香港、新加坡及亞太地區。成立於2016年，PCG已發展成為一家收單機構，擁有所有主要發卡機構和電子錢包網絡的主要會員資格。PCG品牌Yedpay已在香港建立穩固領先的支付業務，而另一業務A3A則通過RESTful API開發了金融雲支付處理系統，這不僅顯著節省成本、減少複雜的流程，還為用戶提供實時交易數據和洞察。此外，PCG核心企業成員BBMSL在支付生態圈擔任支付服務商（Payment Facilitator）角色，專注於為香港中小企業提供全方位電子支付解決方案。作為收單處理商，PCG憑藉其亞洲首個金融雲處理和結算平台，為整個支付行業提供了重要支持。公司將秉持「扎根香港，放眼全球」的策略，以尖端的金融科技賦能商戶，助力全球支付生態實現高質量發展。如有傳媒垂詢，請聯絡：AJA (IR & Communications)庾婉華電話：(852) 9500 4443電郵：avy.yu@ajacapital.com.hk / info@ajacapital.com.hk Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) – In the context of rapid evolution in the robotics industry, Shoucheng Holdings (0697.HK) is gradually transforming from a traditional infrastructure operator into a new platform company with technological attributes. Its newly released 2025 third-quarter financial report not only demonstrates the company’s solid operating fundamentals, but also clearly conveys its strategic path in the robotics industry chain—from “investment layout” toward “application implementation,” gradually building sustainable long-term growth capability.I. Maintaining High-Speed Growth, with Operating Resilience Further EnhancedThe third-quarter report shows that Shoucheng Holdings’ revenue increased 30% year-on-year to HKD 1.215 billion, while net profit attributable to shareholders rose 22% year-on-year to HKD 488 million. The asset operation business continued to expand, and the asset circulation business maintained high-yield contributions, together forming a stable and predictable operating base for the company.Cash and financial assets reached HKD 8.55 billion, while the asset-liability ratio stood at only 31.5%. The company’s financial structure remains sound, providing sufficient “margin of safety” for new investments and business incubation in robotics. On this steady operating foundation, the company announced a HKD 1 billion share repurchase plan over the next three years, with management demonstrating confidence in corporate value through long-term capital commitment.II. Robotics Enter a Dual-Track Stage of “Investment Deepening + Application Validation”Unlike many market participants who remain at the stage of technology demonstrations or laboratory prototypes, Shoucheng Holdings’ robotics layout already shows a “two-line advancement” pattern:One line upward, deepening investment along the industry chain; One line downward, deploying real application scenarios.(1) Investment deepening: Key industry chain enterprises enter their capital-market sprintThrough its industrial funds, Shoucheng Holdings is investing in humanoid robots, embodied intelligence, flying robots, intelligent perception and other directions, focusing resources on globally competitive enterprises. Recent developments include:Unitree Robotics completing IPO counseling, expected to become the first humanoid robot stock in the A-share market;Yunshengchu completing its shareholding restructuring and officially entering the IPO preparation stage;Multiple enterprises expected to be eligible for listing in 2026.The capital-market progress of these enterprises will bring structural returns to Shoucheng Holdings’ equity investment business and open new space for future profit growth.(2) Application validation: Building a “scenario network” for large-scale robot deploymentTo open the path from “technology” to “commercialization,” Shoucheng Holdings has not stopped at the investment level but has simultaneously built consumer-side and urban-side scenario networks. Examples include:The “Taozhu New Craft Bureau” robot technology experience stores launched in Beijing, Chengdu, and airport landmarks, enabling robots to be “visible, usable, and purchasable”;The “Shoucheng W” robot livestreaming studio, which enhances online reach through real-time demonstrations and consumer conversion models;Pilot deployments of automatic charging robots, surgical robots, and educational robots in education, healthcare, and cultural-tourism scenes.This dual-track structure—investment-driven and scenario-driven—allows Shoucheng to form early-stage resource barriers in “data, users, and demand,” becoming a key foundation for long-term expansion in the robotics sector.III. From High-Speed Growth Toward Long-Term Expansion: 2026 as the Key Inflection PointShoucheng Holdings is entering a critical stage of transitioning from “performance growth” to a “growth logic” model.On the financial side, stable asset operations provide a sufficient safety cushion;On the industrial side, investments, scenario deployments, and capital-market progress in robotics are forming a reinforcing cycle.As Unitree Robotics, Yunshengchu and other core enterprises enter the listing channel—combined with the nationwide rollout of experience stores, commercialization of autonomous charging robots, and expanding humanoid robot applications—the company’s robotics business is expected to enter a “quantifiable contribution phase” in 2026.In other words, over the past two years, Shoucheng Holdings has focused on building “infrastructure,” while in the coming years, it will begin to demonstrate “long-term growth attributes.”Based on a foundation of solid financials and forward-looking industrial layout, Shoucheng Holdings is gradually forming a dual-engine model of “robotics investment + application.” As the industry approaches the window of scenario scale-up, the company is already positioned strategically. High-speed growth is the present; long-term growth is the direction. For Shoucheng Holdings, 2026 may only mark the beginning of a new stage. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2025年11月17日 - (亞太商訊 via SeaPRwire.com) - 在機器人產業快速演進的當下，首程控股（0697.HK）正由傳統基礎設施運營商，逐步轉型為具備科技屬性的全新平台公司。其最新發布的 2025 年第三季度財報，不僅展現公司穩健的經營基本面，也清晰傳遞其在機器人產業鏈上的戰略路徑——從「投資布局」走向「應用落地」，並逐步構建可持續的長期成長能力。一、業績保持高速增長，經營韌性進一步增強三季報顯示，首程控股收入同比增長 30% 至 12.15 億港元，歸母淨利潤同比提升 22% 至 4.88 億港元。資產運營業務持續擴張，資產融通業務保持高收益貢獻，兩者共同構成公司穩定且可預期的經營底盤。現金與理財資產規模達 85 億港元，資產負債率僅 31.5%，財務結構穩健，為公司佈局機器人領域的新投資與新業務孵化提供了充裕的「安全邊際」。在穩健經營的基礎上，公司宣布未來三年實施 10 億港元股份回購，管理層以長期資金承諾進一步驗證對公司價值的信心。二、機器人進入「投資深化＋應用驗證」雙軌階段不同於仍停留在技術展示或實驗室階段的市場參與者，首程控股的機器人布局已呈現「雙線推進」的特點：一端向上，深耕產業鏈投資；一端向下，完善應用場景布局。（1）投資深化：產業鏈核心企業陸續邁入資本化衝刺期首程控股透過旗下產業基金，布局人形機器人、具身智能、飛行機器人、智能感知等方向，並將資源集中於具備全球競爭力的企業。近期重要進展包括：宇樹科技完成 IPO 上市輔導，有望成為 A 股人形機器人第一股；雲深處完成股改，正式進入上市籌備階段；多家企業預計於 2026 年具備登陸資本市場的條件。上述企業的資本化進程，將為首程控股的股權投資業務帶來結構性收益，並為未來利潤增長開啟新的空間。（2）應用驗證：構建機器人大規模落地的「場景網絡」為打通機器人從「技術」走向「商業」的通路，首程控股不僅在投資端深度佈局，更同步在消費端與城市端搭建應用場景網絡。例如：「陶朱新造局」機器人科技體驗店已於北京、成都及機場等多個地標落地，實現機器人「看得見、用得上、買得到」；「首程W」機器人直播間以即時展示與消費轉化模型補足線上觸達能力；在教育、醫療、文旅等場景中推動自動充電機器人、手術機器人、教學機器人的落地試點。投資驅動與場景驅動的雙軌模式，使首程能在機器人產業早期階段形成「數據、用戶、需求」三類資源壁壘，奠定長線增長的重要基礎。三、從高速增長邁向長期成長：2026 年將成為關鍵分界線首程控股正處於從「業績增長」轉向「成長邏輯」的關鍵節點。財務端，穩健的資產運營提供足夠安全墊；產業端，機器人業務的投資、應用場景與資本化進展正形成互相強化的正循環。隨著宇樹科技、雲深處等核心企業進入上市通道，加上體驗店全國化布局、自動充電機器人商用化、人形機器人應用持續擴大，公司的機器人業務預計將於 2026 年進入「可量化貢獻期」。換句話說，過去兩年首程控股着力構建的是「基礎設施」；未來幾年，則將開始展現「長期成長性」。首程控股以穩健財務與前瞻產業布局為根基，逐步形成「機器人投資＋應用」的雙輪驅動商業模型。在行業即將迎來場景放量的窗口期，公司已處於結構性優勢位置。高速增長是現在，長期成長是方向，2026 年對首程控股而言，或許只是全新階段的起點。 Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2025年11月17日 - (亞太商訊 via SeaPRwire.com) - 創新實業集團有限公司（簡稱「創新實業」，股份代號：02788.HK）已正式啟動招股，招股時間為11月14日至11月19日，全球發售共計5億股股份，發售價介乎每股10.18港元至10.99港元，最高集資54.95億港元。此次招股，創新實業每手認購單位為500股，入場費約為5,550港元，11月19日截止招股，預計11月24日正式掛牌上市。中金公司與華泰國際為聯席保薦人。依託區域資源優勢，構築電解鋁產業鏈一體化生態創新實業專注於氧化鋁精煉及電解鋁冶煉業務，是中國鋁產業鏈上游的核心參與者。自2012年起，創新實業持續依託內蒙古和山東兩地的區域資源與產業佈局優勢，構建了高自給率，強互補性及協同性的電解鋁產業鏈一體化生態系統，覆蓋能源、氧化鋁精煉、電解鋁冶煉。據CRU報告，按2024年產量計，公司位於內蒙古霍林郭勒的電解鋁冶煉廠為華北第四大電解鋁生產基地，公司為中國第十二大電解鋁生產商。公司位於內蒙古的子公司內蒙創源於2024年獲工信部授予國家級綠色工廠榮譽。在能源環節，公司已建立自有火力發電站和發電設施，並正加快建設以綠電為主的發電站及發電設施，為生產提供低成本且穩定的電力保障。根據CRU報告，2024年公司電力自給率約為88%，且顯著高於約57%同業平均水平，充分體現出其在成本控制與供應安全方面的領先優勢。財務表現穩健增長 盈利能力持續增強創新實業財務基礎穩健，收入與利潤均保持強勁增長勢頭。根據招股書顯示，公司總收入由2022年的人民幣134.90億元增長至2024年的人民幣151.63億元，年復合增長率約為6.0%。截至2025年5月31日止前五個月，公司錄得收入人民幣72.14億元，同比上升22.6%，顯示出持續增長動能。盈利能力方面，公司實現質的飛躍。淨利潤由2022年的人民幣9.13億元大幅躍升至2024年的人民幣26.30億元，年復合增長率超過60%。這一顯著提升主要得益於成本結構優化與規模效應的釋放。公司毛利率在2024年上升至28.2%，較往年水平顯著改善，反映出其產業鏈一體化模式在成本波動週期中的穩定性與高效性。截至2025年前五個月，公司淨利潤為人民幣8.56億元，盈利表現依然穩健。錨定全球化佈局 開啟價值新篇面對國內電解鋁產能逐步接近政策上限的行業格局，創新實業前瞻性地將發展視野延伸至全球市場，重點把握「一帶一路」沿線國家在新能源及基礎設施建設方面對鋁產品的強勁需求。公司正積極推進沙特阿拉伯50萬噸電解鋁產業鏈綜合項目。該項目依託沙特豐富的能源資源與低成本電力，預計投產後生產成本將低於全球平均水平，有望成為公司全球化佈局的重要支撐點。根據招股書顯示，本次募集資金的50%將用於拓展海外產能，包括建設一家電解鋁冶煉廠及購買及安裝生產設施；40%將用於建設綠色能源項目；10%將用於補充營運資金及一般公司用途。未來，創新實業將持續依託其資源稟賦和產業鏈協同優勢，在鞏固國內核心產能的同時，加快海外戰略佈局步伐。公司將以穩健的財務管理和卓越的運營效率，為股東與投資者創造可持續的長期價值，推動中國鋁工業邁向更高質量的發展階段。 Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

DUBAI, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) - On October 31, 2025, General Atomics Aeronautical Systems, Inc. (GA-ASI) completed its "third lifetime" of full-scale fatigue (FSF) testing for the MQ-9B Remotely Piloted Aircraft (RPA). Completion of FSF testing for the third and final lifetime includes a total of 120,000 operating hours (40,000+ flight hours per aircraft life) for the RPA and is a key milestone in validating the design of the airframe. The testing verifies the airframe structural integrity in support of certification to the NATO STANAG 4671 standard.The aim of the testing is to identify any potential structural deficiencies ahead of fleet usage and assist in developing inspection and maintenance schedules for the airframe. Test results will be used as documentation for certification and will form the basis for in-service inspections of structural components."The completion of our full-scale fatigue test validates years of GA-ASI design and analysis efforts," said GA-ASI President David R. Alexander. "The first two lifetimes simulated the operation of the aircraft under normal conditions, and the third intentionally inflicted damage to the airframe's critical components to demonstrate its ability to tolerate operational damage that could occur over the lifetime of the aircraft."Testing was conducted from December 13, 2022, through October 31, 2025, at Wichita State University's National Institute for Aviation Research in Wichita, Kansas. The airframe tested was a production airframe purpose-built to support the test campaign.MQ-9B is GA-ASI's most advanced RPA and includes the SkyGuardian® and SeaGuardian® models as well as the new Protector RG Mk1 that is currently being delivered to the United Kingdom's Royal Air Force (RAF). In addition to the RAF, GA-ASI has MQ-9B procurement contracts with Belgium, Canada, Japan, Taiwan, Poland, India, Denmark, and the U.S. Air Force in support of the Special Operations Command. MQ-9B has also been featured in various U.S. Navy exercises, including Northern Edge, Integrated Battle Problem, RIMPAC, and Group Sail.About GA-ASIGeneral Atomics Aeronautical Systems, Inc., is the world's foremost builder of Unmanned Aircraft Systems (UAS). Logging more than 9 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle®, MQ-20 Avenger®, and MQ-9B SkyGuardian®/SeaGuardian®. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.For more information, visit www.ga-asi.com.Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc., registered in the United States and/or other countries.Contact InformationGA-ASI Media Relationsasi-mediarelations@ga-asi.com(858) 524-8101SOURCE: General Atomics Aeronautical Systems, Inc. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

DUBAI, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) - Following their announcement to bring Airborne Early Warning and Control (AEW&C) capability to the world's leading Remotely Piloted Aircraft (RPA) platform, General Atomics Aeronautical Systems, Inc. (GA-ASI) and Saab will now team up to demonstrate the capability in the summer of 2026. The demo will be conducted at GA-ASI's Desert Horizon flight operations facility in Southern California using a GA-ASI MQ-9B equipped with AEW&C supplied by Saab.In partnership with Saab, a leading company in AEW&C systems, GA-ASI is pairing Saab's AEW sensors with the world's longest-range, highest-endurance RPA, the MQ-9B. At sea or over land, adding AEW capabilities on MQ-9B enables persistent air surveillance and enables AEW in areas of the world where it doesn't currently exist or is unaffordable, such as for navy aircraft carriers at sea."Adding AEW&C to the MQ-9B brings a critical new capability to our platform," said GA-ASI President David R. Alexander. "We want to deliver a persistent AEW&C solution to our global operators that will protect them against sophisticated cruise missiles as well as simple but dangerous drone swarms."MQ-9B models include the SkyGuardian® and SeaGuardian®, the United Kingdom's MQ-9B variant known as Protector, and the new MQ-9B STOL (Short Takeoff and Landing) configuration currently in development.The AEW solution for MQ-9B will offer critical aloft sensing to defend against tactical air munitions, guided missiles, drones, fighter and bomber aircraft, and other threats. Operational availability for a medium-altitude, long-endurance UAS is the highest of any military aircraft, and as an unmanned platform, its aircrews are not put into harm's way.GA-ASI and Saab's AEW offering will span a wide range of applications, including early detection and warning; long-range detection and tracking; and simultaneous target tracking and flexible combat system integration - all over line-of-sight and SATCOM connectivity.About GA-ASIGeneral Atomics Aeronautical Systems, Inc., is the world's foremost builder of Unmanned Aircraft Systems (UAS). Logging more than 9 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle®, MQ-20 Avenger®, and MQ-9B SkyGuardian®/SeaGuardian®. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.For more information, visit www.ga-asi.com.Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc., registered in the United States and/or other countries.Contact InformationGA-ASI Media Relationsasi-mediarelations@ga-asi.com(858) 524-8101SOURCE: General Atomics Aeronautical Systems, Inc. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

迪拜，阿聯酋, 2025年11月17日 - (亞太商訊 via SeaPRwire.com) - 在此前宣布將空中預警與指揮控制（AEW&C）能力整合到全球領先的遠程駕駛航空器（RPA）平台後，通用原子航空系統公司（GA-ASI）與 Saab 現已確認，將於 2026 年夏季共同進行能力展示。此次展示將在 GA-ASI 位於南加州的 Desert Horizon 飛行運營設施進行，屆時將使用配備 Saab 提供的 AEW&C 系統的 GA-ASI MQ-9B。與 AEW&C 系統領域的領先企業 Saab 合作，GA-ASI 正將 Saab 的空中預警感測器與全球航程最遠、續航時間最長的遠程駕駛航空器 MQ-9B 進行整合。無論在海上還是陸地，在 MQ-9B 上加入 AEW 能力，都能實現持續的空中監視，並為目前尚無或無法負擔此能力的地區（例如海上執行任務的海軍航母）提供空中預警。GA-ASI 總裁 David R. Alexander 表示：「將 AEW&C 加入 MQ-9B，為我們的平台帶來了關鍵的新能力。我們希望為全球用戶提供一種持續性的 AEW&C 解決方案，使他們能夠防禦先進的巡航導彈，以及簡單但危險的無人機蜂群攻擊。」MQ-9B 的機型包括 SkyGuardian®、SeaGuardian®、英國版本的 MQ-9B（稱為 Protector），以及目前正在研發中的 MQ-9B STOL（短距起降）構型。MQ-9B 的 AEW 解決方案將提供關鍵的高空感知能力，用於防禦戰術空中彈藥、制導導彈、無人機、戰鬥機和轟炸機等各類威脅。中空長航時無人機系統的任務可用性是所有軍機中最高的之一，並且作為無人平台，其機組人員不會面臨生命危險。GA-ASI 與 Saab 提供的 AEW 方案將涵蓋廣泛用途，包括：早期探測與預警、遠程探測與追蹤、對多個目標的同步追蹤，以及靈活的作戰系統整合——這一切都可透過視距鏈路與衛星通信（SATCOM）實現。關於 GA-ASI通用原子航空系統公司（General Atomics Aeronautical Systems, Inc.，GA-ASI）是全球領先的無人航空系統（UAS）製造商。GA-ASI 的 Predator® 系列無人機已累計超過 900 萬飛行小時，並在過去 30 年內持續服役，旗下機型包括 MQ-9A Reaper®、MQ-1C Gray Eagle® 25M、MQ-20 Avenger® 以及 MQ-9B SkyGuardian®/SeaGuardian®。公司致力於提供長航時、多任務解決方案，以實現持續的態勢感知與快速打擊能力。欲了解更多資訊，請訪問 www.ga-asi.com 。Avenger、EagleEye、Grey Eagle、Lynx、Predator、Reaper、SeaGuardian 和 SkyGuardian 是 General Atomics Aeronautical Systems, Inc. 在美國和/或其他國家註冊的商標。聯絡方式GA-ASI 媒體關係asi-mediarelations@ga-asi.com(858) 524-8101來源: General Atomics Aeronautical Systems, Inc. Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Nov 17, 2025 - (ACN Newswire via SeaPRwire.com) – As the public subscription for Chuangxin Industries Holdings Limited (“Chuangxin Industries”; Stock Code: 02788.HK) entered its second day, the market response has been overwhelmingly positive. The company officially launched its initial public offering on November 14, 2025, with 17 cornerstone investors’ participation—a move that further bolsters investor confidence. As a leading player in China’s upstream aluminum sector, the company is offering 500 million shares subject to the Over-allotment Option, within a price range of HK$10.18 – HK$10.99 per share, aiming to raise up to HK$5,495 million. The public subscription period will run until November 19, 2025, with an entry fee of approximately HK$5,550 for a board lot of 500 shares, ahead of its expected listing on the HKEX Main Board on November 24, 2025.Chuangxin Industries specializes in alumina refining and aluminum smelting—two of the most value-added segments of the aluminum industry chain. With a proven track record of cost leadership, proactive green transition initiatives, and a highly integrated operational ecosystem, the company is strategically positioned to capitalize on growing global demand for aluminum—particularly low-carbon aluminum, which is increasingly favored in sectors such as electric vehicles, renewable energy infrastructure, and consumer electronics.One of the standout features of Chuangxin Industries is its strategic presence in resource-rich regions such as Inner Mongolia and Shandong Province. The company’s aluminum smelter in Huolinguole ranked as the fourth-largest production base of electrolytic aluminum in 2024 in North China. This location offers the company a decisive advantage in power costs, supported by self-generation capabilities and abundant local energy resources. In 2024, the company’s coal-fired power cost stood at just RMB0.37 per kWh, notably below the national average of RMB0.43 per kWh. By May 2025, this figure had further dropped to RMB0.33 per kWh—a clear indicator of continuous operational optimization.This low-cost energy structure has enabled Chuangxin Industries to achieve a cash cost of aluminum of approximately RMB15,112 per ton in 2024, significantly lower than the industry average of approximately RMB17,700 per ton in China. According to CRU, the company ranked among the top 5% of all aluminum smelting companies in China in terms of cost efficiency, reinforcing its competitive edge both domestically and globally.Aligned with China’s national goals to peak carbon emissions by 2030 and achieve carbon neutrality by 2060, Chuangxin Industries is moving decisively toward green power adoption. The company is currently constructing wind and solar power plants with a total projected installed capacity of 1,750.0 MW. By the end of 2026, it aims to source over 50% of its energy from renewables—doubling the national mandate of 25%. This transition not only supports environmental targets but also drives down long-term operational expenses. Based on the estimates, the delivered cost of green power is expected to be as low as RMB0.10–0.18 per kWh, substantially below current coal-powered rates, thereby enhancing profitability and insulating the company from potential carbon price increases.Another pillar of Chuangxin Industries’ competitive strength lies in its self-sufficient operational model. Electricity represents a major portion of production costs in aluminum smelting, and the company’s electricity self-sufficiency rate reached approximately 88% in 2024, far exceeding the industry average of around 57%. This high level of energy autonomy not only stabilizes production but also shields the company from grid price volatility. In addition, the company maintains a high rate of alumina self-sufficiency, with an annual designed production capacity of 788.1kt for electrolytic aluminum and 1,200.0 kt for alumina—ensuring a reliable and cost-effective supply of key raw materials.Geographic advantages further amplify Chuangxin Industries’ market positioning. Its Inner Mongolia smelter is located within a 25 km radius of downstream customers boasting a combined production capacity of over 1.9 million tons—far exceeding its own annual output of 788.1 kt. This proximity not only reduces transportation costs but also enables the sale of liquid aluminum, which must be delivered within a narrow 50 km radius. Supported by its high rates of self-sufficiency in both electricity and alumina supply, Chuangxin Industries has established a synergistic, integrated ecosystem that ensures unique competitiveness across the electrolytic aluminum industry chain and shields the company from market volatility. Financially, Chuangxin Industries has demonstrated impressive growth and operational efficiency. Revenue increased from RMB13.8 billion in 2023 to RMB15.2 billion in 2024, and surged by 22.6% year-on-year to RMB7.2 billion in the first five months of 2025. Gross profit margin improved markedly from 16.9% in 2023 to 28.2% in 2024, reflecting both improved cost control and favorable industry dynamics. These results underscore the company’s ability to capitalize on market upcycles while maintaining structural cost advantages.Looking ahead, Chuangxin Industries is not resting on its achievements. The company has unveiled plans to establish a 500 kt aluminum smelting facility in Yanbu, Saudi Arabia—a strategic move that will leverage the country’s low-cost natural gas resources and prime location near the Red Sea. This expansion will facilitate efficient export of aluminum products to markets in Europe and the United States via the Suez Canal.The IPO of Chuangxin Industries arrives at a pivotal moment, with global aluminum demand being steadily driven by transitions in transportation, energy, and digital infrastructure. With its industry-leading cost structure, clear green transformation roadmap, and fully integrated value chain, Chuangxin Industries is not merely a commodity producer—it is a forward-looking industrial operator committed to sustainable and high-quality growth. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2025年11月17日 - (亞太商訊 via SeaPRwire.com) - 由香港中國金融協會主辦的2025年度「跨境金融及金融創新服務大獎」已完成全部評審工作。秉持服務國家戰略的初衷，本屆大獎以「破局金融未來」為主題，聚焦跨境金融、科技金融與綠色金融等前沿領域，徵集期間收到眾多金融機構、持牌人士及業務團隊提交的創新案例。本屆大獎設立嚴格的評審標準，終評由業內資深專家組成評審委員會，從創新性、實效性、可推廣性等多個維度對參選案例進行全面評估。最終獲獎名單將於11月27日「香港數字金融中心建設的機遇與挑戰」暨「跨境金融及金融創新服務大獎」頒獎典禮上隆重揭曉,香港政商界領袖及金融行業專家等重磅嘉賓亦將蒞臨典禮,共同見證獲獎團隊誕生, 共襄盛舉。香港發揮「一國兩制」優勢 打造金融創新「試驗田」香港中國金融協會主席孟羽強調，在全球金融格局深刻變革的背景下，香港要充分發揮背靠祖國、聯通世界的獨特優勢，積極服務國家金融強國戰略。他指出，香港作為中國連接海外的第一站，不僅肩負金融橋頭堡的使命，更是金融科技創新的重要「試驗田」。孟羽表示，本屆大獎将緊扣跨境金融與科技創新深度融合的時代命題，期望能發掘更多具有引領性的創新實踐，為國家金融改革開放積累寶貴經驗。他强调，香港特區政府在2025年施政報告中提出「穩健發展金融科技」的要求與「綠色可持續金融發展」的目標，為金融行業轉型升級指明方向。為積極響應政府政策導向，孟羽表示，本屆大獎將重點聚焦科技金融、綠色金融等前沿領域，助力跨境金融服務提質升級。香港擔當大灣區與「一帶一路」建設結合點香港中國金融協會副主席鄒傳指出，大灣區建設與「一帶一路」建設的結合點在香港，香港作為大灣區的金融核心和金融產品設計中心，憑藉完善的法治環境和市場體系，為大灣區企業、產業提供了資本化定價的有力支撐和出海的最佳平台。談及中資企業出海，鄒傳表示，隨著中國企業國際化進程加速，香港以其與全球接軌的法律體系和市場架構，正成為企業全球化佈局的「首選安全港」。他補充，本屆大獎特別關注那些能夠有效幫助中資企業應對全球化挑戰的金融創新方案。業界齊聚盛會 頒獎典禮見證創新成果業界專家已於11月期間對參選案例進行專業評審，所有參評案例均為2024年7月至2025年10月期間實際落地執行的金融服務方案，涵蓋銀行、證券、保險、資產管理及金融科技等多個專業領域。目前，評審工作圓滿完成，最終獲獎名單將於11月27日香港中國金融協會2025年度論壇「香港數字金融中心建設的機遇與挑戰」暨「跨境金融及金融創新服務大獎」頒獎典禮上隆重揭曉。業界持續鼓勵金融機構善用科技和創新，推動金融機構優化和跨境金融服務完善，支持香港本地、粵港澳大灣區以至其他地方的經濟活動。期望本屆大獎為香港金融業的創新發展注入新的動力，並為跨境金融服務的未來發展方向提供重要參考。如欲了解更多活動詳情，歡迎電郵至：HCFA_Awards@tfisec.com。 Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Belem, Brazil, Nov 15, 2025 - (ACN Newswire via SeaPRwire.com) - The Government of Indonesia reaffirmed its determination to lead global efforts in tackling climate change and accelerating the transition toward Net Zero Emissions (NZE) by 2060 or sooner through fair and inclusive collaboration.Indonesia's Special Envoy of the President for Climate and Energy, Hashim Djojohadikusumo, speaking at the Leaders Summit during the 30th Conference of the Parties (COP30) in Belém, Brazil, Thursday (Nov. 6). The Government of Indonesia reaffirmed its commitment to leading global efforts in mitigating climate change and accelerating the transition toward Net Zero Emissions by 2060 or sooner. (Photo: Official UN Web TV.)The statement was delivered by Hashim Djojohadikusumo, Special Envoy of the President of the Republic of Indonesia, representing President Prabowo Subianto at the Leaders Summit during the 30th Conference of the Parties (COP30), United Nations Climate Change Conference, in Belém, Brazil, on Thursday (6/11)."Indonesia came to Belém with a clear message: we remain steadfast in our commitment to strengthening national climate action and are ready to work with other countries to advance initiatives that are inclusive, ambitious, and results-driven," said Hashim.He noted that President Prabowo had reaffirmed Indonesia's commitment to the Paris Agreement to achieve NZE no later than 2060—or sooner. Indonesia is also targeting 8 percent economic growth through a sustainable development strategy that is consistently formulated and implemented.In its Second Nationally Determined Contribution (SNDC), Indonesia aims to reduce emissions by 1.2 to 1.5 gigatons of CO2 equivalent (CO2e) by 2035. This target will be supported by increasing the renewable energy mix to 23 percent by 2030 and advancing new technologies, including nuclear energy, within the framework of the green energy transition."Recently, President Prabowo issued Presidential Regulation No. 109 on Waste-to-Energy and Presidential Regulation No. 110 on Carbon Economic Value. These two regulations lay a vital foundation for building a national decarbonization system and enhancing control over greenhouse gas emissions," Hashim added.This message was echoed by Hanif Faisol Nurofiq, Minister of Environment and Head of the Environmental Control Agency, who underlined Indonesia's commitment to a just and equitable green economy."COP30 marks a defining moment to prove that green development is not only possible but also beneficial. Indonesia leads by action, not by promises," said Hanif.He emphasized that the principle of climate justice must remain at the heart of every energy transition policy."Climate justice means ensuring that no one is left behind. Indonesia is ready to lead by example—integrating policy, science, and social values for a better and fairer future," he said.President Director of PT PLN (Persero) Darmawan Prasodjo expressed PLN's readiness to realize President Prabowo's vision of advancing Indonesia's energy transition through the implementation of the Electricity Supply Business Plan (RUPTL) 2025–2034."About three months ago, under the direction of President Prabowo Subianto and Minister of Energy and Mineral Resources Bahlil Lahadalia, Indonesia launched its new RUPTL. Over the next decade, Indonesia plans to add 69.5 gigawatts (GW) of generation capacity—around 76 percent of which will come from renewable energy and storage technologies," Darmawan said.He added that the new RUPTL serves as PLN's strategic roadmap to accelerate the clean energy transition toward NZE 2060 or sooner. The plan not only ensures a reliable electricity supply but also stimulates green job creation, expands electrification in frontier, outermost, and underdeveloped (3T) regions, and strengthens national energy resilience."By prioritizing renewable energy, PLN is committed to building a power system that is cleaner, more inclusive, and sustainable. We believe that through synergy with all stakeholders, Indonesia's ambitious energy transition targets can be achieved effectively and on time," Darmawan concluded.About PLNPT PLN (Persero) is Indonesia's state-owned electricity company, committed to continuous innovation and delivering the best service to its customers. PLN drives its Transformation 2.0 agenda with the vision of becoming a Top 500 Global Company and the No. 1 choice for energy solutions. This is achieved through sustainable business growth, end-to-end digitalization, energy transition initiatives supporting Net Zero Emissions (NZE), and the development of world-class human capital.Contact:Gregorius Adi TriantoExecutive Vice President, Corporate Communications & CSR, PT PLNTel. +62 21 7261122Fax. +62 21 7227059       Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

倫敦, 2025年11月15日 - (亞太商訊 via SeaPRwire.com) - 兩項發表於期刊《Animals》的先驅性研究，深入探討狗與貓飼主對更永續的寵物食品選項的看法。由 Jenny L. Mace、Alexander Bauer、Andrew Knight 與 Billy Nicholles 主導，研究為伴侶動物領域中替代蛋白與植物性飲食的潛力帶來新的見解。研究一 — 狗：〈消費者對永續狗糧的接受度：2,639 名狗飼主的調查〉在第一項研究 中，研究團隊調查了全球 2,639 名狗飼主。約有 84% 的受訪者目前餵食傳統或生肉為主的飲食。然而，其中有高達 43% 表示他們仍會考慮至少一種類型的更永續狗糧（例如純素、素食或培養肉配方）。在各種替代選項中，最被接受的是培養肉為主的狗糧（佔這些受訪者的 24%），相比之下，素食狗糧為 17%，純素狗糧為 13%。當被問到這些替代品需要具備哪些特點才會被選擇時，最重要的考量為營養健全性（85% 選擇），其次是良好的寵物健康狀況（83%）。研究二 — 貓：〈消費者對永續貓糧的接受度：1,380 名貓飼主的調查〉配套研究收集了 1,380 名貓飼主的回覆。共有 89% 的受訪者餵食傳統或生肉為主的飲食。然而，稍多於一半──51%──認為至少有一種更永續的選項是可以接受的。最受歡迎的替代方案是以培養肉為基礎的飲食（佔該組別的 33%），其次為純素飲食（18%）。與狗的調查類似，替代飲食之所以會被選擇，最重要的因素為良好的寵物健康結果（83% 選擇）以及營養健全性（80%）。消費者之間的差異兩項研究均發現，那些本身減少或避免食用肉類的飼主，對寵物的替代飲食顯著更為開放；受教育程度較高者亦然。年齡與地區差異也明顯存在：較年長的消費者，以及來自英國的受訪者，通常比其他歐洲國家、北美或大洋洲的受訪者更不願接受替代飲食，儘管這些差異往往未達統計顯著。這代表什麼意義這兩項平行研究發表之際，傳統寵物食品生產在環境與倫理層面的影響正逐漸受到公眾關注。正如研究共同作者、獸醫學教授 Andrew Knight 所指出的：「近期研究顯示，我們的狗與貓合計消耗了全部養殖動物中的相當大比例。以植物性成分或培養肉為基礎的寵物飲食，可能改變整個寵物食品體系，減少對養殖動物及環境所造成的不良影響。」在全球已快速增長、數以億計的狗與貓之中，即使只有少部分轉向較低影響的飲食，也可能帶來顯著的效益。共同作者 Billy Nicholles 也總結道：「這些研究結果對快速成長的替代寵物食品產業具有重要價值，使寵物食品公司能夠透過基於證據的精準推廣，加速其成長並吸引新客戶。」對產業與獸醫實務的影響對寵物食品公司而言，訊息十分明確：推出永續飲食產品線不僅是生產創新的問題，同時也關乎建立信任。有關營養健全性與健康結果的清楚資訊，對飼主是否願意採用新產品具有重大影響。對獸醫從業者與動物福利組織而言，這些研究結果凸顯了知情溝通的重要性。如果飼主願意接受替代選項，但對寵物的健康結果仍感到不確定，那麼基於證據的專業指引就成為促進採用的關鍵因素。更多資訊Andrew KnightVeterinary Professor of Animal WelfareAndrew.Knight@murdoch.edu.au來源: Sustainable Pet Food Foundation Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com